Alnylam Pharmaceuticals, Inc. is a leading biopharmaceutical company at the forefront of RNA interference (RNAi) technology, dedicated to the discovery, development, and commercialization of innovative therapeutics that address genetic diseases. Headquartered in Cambridge, Massachusetts, Alnylam has established a robust pipeline of RNAi-based therapies and has achieved significant milestones, including the successful launch of its first commercial product. With a strong commitment to scientific advancement and a focus on transformative medicine, Alnylam aims to set new standards in the treatment of rare and prevalent diseases, positioning itself as a key player in the biopharmaceutical landscape.
Click "Analyze" to generate stock analysis
ALNY Price Trend and Signals
ALNY Option Volumes & Open Interests (aggregated)
ALNY Put Call Ratios and IV (aggregated)
ALNY Financials
2025-10-30Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-30Somewhat Bearishprice_signal
Monthly low detected.
2025-10-29Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-20Somewhat Bullishprice_signal
Yearly high detected.
2025-10-17Somewhat Bullishprice_signal
Monthly high detected.
2025-10-16Somewhat Bullishprice_signal
Monthly high detected.
2025-10-15Somewhat Bullishprice_signal
Monthly high detected.
2025-10-14Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-14Somewhat Bullishprice_signal
Monthly high detected.
2025-10-13Somewhat Bullishprice_signal
Monthly high detected.
2025-10-09Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-09Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-09Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-09Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.